t:slim X2 Insulin Pump

The smallest insulin pump is also the only pump capable of remote feature updates using a personal computer.(1, 2) And now the t:slim X2™ Insulin Pump with Dexcom G5® Mobile CGM integration is the first CGM-enabled pump that is approved to let you make treatment decisions without pricking your finger.(3)\1. 38% smaller than MiniMed 630G and 670G and 25% smaller than MiniMed 530G, Animas Vibe and Omnipod System. Data on file, Tandem Diabetes Care.2. Software updates and new features are subject to future FDA approvals. Charges may apply.3. CGM-based treatment requires fingersticks for calibration; may result in hypoglycemia if calibration not performed, when taking acetaminophen, or if symptoms/expectations do not match CGM readings.\Indications for Use: RX ONLY. The t:slim X2 Insulin Delivery System is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin for individuals 6 years of age or greater. The t:slim X2 Insulin Pump can be used solely for continuous insulin delivery and/or as part of the t:slim X2 System to receive and display continuous glucose measurements from the Dexcom G5 Mobile Sensor and Transmitter. The t:slim X2 System also includes continuous glucose monitoring (CGM) indicated for the management of diabetes. The Dexcom G5 Mobile CGM is designed to replace fingerstick blood glucose testing for diabetes treatment decisions. The t:slim X2 System combined with the Dexcom G5 Mobile CGM aids in the detection of episodes of hyperglycemia and hypoglycemia, facilitating both acute and long-term therapy adjustments, which may minimize these excursions. Interpretation of the t:slim X2 System results should be based on the trends and patterns seen with several sequential readings over time. The device is indicated for use with NovoLog or Humalog U-100 insulin.

Company’s Keywords: